Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron May 20, 2021 7:11pm

81 Views

Post# 33245593

todays trades

House Positions for C:VXL from 20210520 to 20210520

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
2 RBC	23,000	2,070	0.09	0			23,000	-2,070
7 TD Sec	24,534	2,259	0.092	3,002	285	0.095	21,532	-1,974
79 CIBC	24,000	2,165	0.09	5,000	450	0.09	19,000	-1,715
85 Scotia	53,140	5,047	0.095	35,375	3,183	0.09	17,765	-1,864
80 National Bank	17,966	1,623	0.09	6,209	568	0.091	11,757	-1,055
212 Virtu	1,375	123	0.089	0			1,375	-123
124 Questrade	110	10	0.091	0			110	-10
68 Leede	520	46	0.088	2,059	195	0.095	-1,539	149
33 Canaccord	1,000	90	0.09	35,000	3,320	0.095	-34,000	3,230
1 Anonymous	21,000	1,890	0.09	80,000	7,325	0.092	-59,000	5,435
TOTAL	166,645	15,323	0.092	166,645	15,326	0.092	0	3